Annual CFI
$190.94 M
+$202.87 M+1700.66%
31 December 2023
Summary:
REGENXBIO annual cash flow from investing activities is currently $190.94 million, with the most recent change of +$202.87 million (+1700.66%) on 31 December 2023. During the last 3 years, it has risen by +$68.18 million (+55.54%). RGNX annual CFI is now at all-time high.RGNX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$50.26 M
+$50.53 M+18852.99%
30 September 2024
Summary:
REGENXBIO quarterly cash flow from investing activities is currently $50.26 million, with the most recent change of +$50.53 million (+18852.99%) on 30 September 2024. Over the past year, it has increased by +$11.60 million (+30.01%). RGNX quarterly CFI is now -20.34% below its all-time high of $63.09 million, reached on 31 March 2023.RGNX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
$97.15 M
+$11.60 M+13.56%
30 September 2024
Summary:
REGENXBIO TTM cash flow from investing activities is currently $97.15 million, with the most recent change of +$11.60 million (+13.56%) on 30 September 2024. Over the past year, it has dropped by -$86.52 million (-47.11%). RGNX TTM CFI is now -50.95% below its all-time high of $198.06 million, reached on 30 June 2023.RGNX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RGNX Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1700.7% | +30.0% | -47.1% |
| 3 y3 years | +55.5% | +212.1% | +154.4% |
| 5 y5 years | +168.3% | -3.9% | +694.8% |
RGNX Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +147.0% | -20.3% | +123.2% | -51.0% | +123.9% |
| 5 y | 5 years | at high | +147.0% | -20.3% | +123.2% | -51.0% | +123.9% |
| alltime | all time | at high | +147.0% | -20.3% | +123.2% | -51.0% | +123.9% |
REGENXBIO Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $50.26 M(<-9900.0%) | $97.15 M(+13.6%) |
| June 2024 | - | -$268.00 K(-102.0%) | $85.55 M(-39.3%) |
| Mar 2024 | - | $13.18 M(-61.2%) | $141.03 M(-26.1%) |
| Dec 2023 | $190.94 M(-1700.7%) | $33.97 M(-12.1%) | $190.94 M(+4.0%) |
| Sept 2023 | - | $38.66 M(-30.0%) | $183.67 M(-7.3%) |
| June 2023 | - | $55.22 M(-12.5%) | $198.06 M(+39.7%) |
| Mar 2023 | - | $63.09 M(+136.3%) | $141.76 M(-1288.3%) |
| Dec 2022 | -$11.93 M(-97.1%) | $26.70 M(-49.7%) | -$11.93 M(-95.3%) |
| Sept 2022 | - | $53.04 M(-5006.8%) | -$254.99 M(-12.7%) |
| June 2022 | - | -$1.08 M(-98.8%) | -$291.93 M(+3.1%) |
| Mar 2022 | - | -$90.59 M(-58.1%) | -$283.05 M(-30.4%) |
| Dec 2021 | -$406.64 M(-431.3%) | -$216.36 M(-1443.8%) | -$406.64 M(+127.5%) |
| Sept 2021 | - | $16.10 M(+106.4%) | -$178.71 M(+11.1%) |
| June 2021 | - | $7.80 M(-103.6%) | -$160.82 M(+29.6%) |
| Mar 2021 | - | -$214.18 M(-1951.2%) | -$124.13 M(-201.1%) |
| Dec 2020 | $122.76 M(+31.2%) | $11.57 M(-66.0%) | $122.76 M(-2.1%) |
| Sept 2020 | - | $34.00 M(-23.6%) | $125.34 M(-12.7%) |
| June 2020 | - | $44.48 M(+36.0%) | $143.62 M(+18.9%) |
| Mar 2020 | - | $32.71 M(+131.1%) | $120.81 M(+29.1%) |
| Dec 2019 | $93.56 M | $14.15 M(-72.9%) | $93.56 M(+665.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2019 | - | $52.27 M(+141.2%) | $12.22 M(-106.9%) |
| June 2019 | - | $21.67 M(+296.9%) | -$176.77 M(-25.4%) |
| Mar 2019 | - | $5.46 M(-108.1%) | -$236.81 M(-15.2%) |
| Dec 2018 | -$279.36 M(+5732.1%) | -$67.18 M(-50.9%) | -$279.36 M(+31.0%) |
| Sept 2018 | - | -$136.72 M(+256.4%) | -$213.32 M(+268.9%) |
| June 2018 | - | -$38.37 M(+3.5%) | -$57.83 M(+28.4%) |
| Mar 2018 | - | -$37.09 M(+3144.6%) | -$45.04 M(+840.3%) |
| Dec 2017 | -$4.79 M(-124.7%) | -$1.14 M(-106.1%) | -$4.79 M(-134.7%) |
| Sept 2017 | - | $18.77 M(-173.4%) | $13.79 M(+185.9%) |
| June 2017 | - | -$25.57 M(-908.6%) | $4.82 M(-85.5%) |
| Mar 2017 | - | $3.16 M(-81.9%) | $33.29 M(+71.7%) |
| Dec 2016 | $19.39 M(-111.8%) | $17.43 M(+77.9%) | $19.39 M(-113.6%) |
| Sept 2016 | - | $9.80 M(+238.7%) | -$142.39 M(-16.9%) |
| June 2016 | - | $2.89 M(-126.9%) | -$171.33 M(-1.8%) |
| Mar 2016 | - | -$10.74 M(-92.6%) | -$174.43 M(+6.5%) |
| Dec 2015 | -$163.80 M(<-9900.0%) | -$144.34 M(+654.0%) | -$163.80 M(+741.8%) |
| Sept 2015 | - | -$19.14 M(+9059.8%) | -$19.46 M(+6077.5%) |
| June 2015 | - | -$209.00 K(+97.2%) | -$315.00 K(+197.2%) |
| Mar 2015 | - | -$106.00 K | -$106.00 K |
| Dec 2014 | $0.00 | - | - |
FAQ
- What is REGENXBIO annual cash flow from investing activities?
- What is the all time high annual CFI for REGENXBIO?
- What is REGENXBIO annual CFI year-on-year change?
- What is REGENXBIO quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for REGENXBIO?
- What is REGENXBIO quarterly CFI year-on-year change?
- What is REGENXBIO TTM cash flow from investing activities?
- What is the all time high TTM CFI for REGENXBIO?
- What is REGENXBIO TTM CFI year-on-year change?
What is REGENXBIO annual cash flow from investing activities?
The current annual CFI of RGNX is $190.94 M
What is the all time high annual CFI for REGENXBIO?
REGENXBIO all-time high annual cash flow from investing activities is $190.94 M
What is REGENXBIO annual CFI year-on-year change?
Over the past year, RGNX annual cash flow from investing activities has changed by +$202.87 M (+1700.66%)
What is REGENXBIO quarterly cash flow from investing activities?
The current quarterly CFI of RGNX is $50.26 M
What is the all time high quarterly CFI for REGENXBIO?
REGENXBIO all-time high quarterly cash flow from investing activities is $63.09 M
What is REGENXBIO quarterly CFI year-on-year change?
Over the past year, RGNX quarterly cash flow from investing activities has changed by +$11.60 M (+30.01%)
What is REGENXBIO TTM cash flow from investing activities?
The current TTM CFI of RGNX is $97.15 M
What is the all time high TTM CFI for REGENXBIO?
REGENXBIO all-time high TTM cash flow from investing activities is $198.06 M
What is REGENXBIO TTM CFI year-on-year change?
Over the past year, RGNX TTM cash flow from investing activities has changed by -$86.52 M (-47.11%)